Page 8 - Program On Regulation News Today

Stalled confirmatory trials and lax enforcement plague the Food and Drug Administration's accelerated approval pathway for pharmaceuticals that target urgent medical needs.

Stalled confirmatory trials and lax enforcement plague the Food and Drug Administration's accelerated approval pathway for pharmaceuticals that target urgent medical needs.

Eddie Cliff, MPH ’22, cares just as deeply about the well-being of his patients as he does about improving health systems as a whole.

President Joe Biden is eyeing legal avenues through which he could protect access to abortion if the Supreme Court overturns Roe v. Wade.

Congress may have a limited window to pass legislation that could curb skyrocketing drug prices.

This Viewpoint documents the history, value, and success of the 340B Pricing Program, which is under threat from pharmaceutical corporations’ withdrawal and fro

Healthcare

BioPharma

The Supreme Court Thursday blocked the Biden administration’s vaccine mandate for large employers. What happens now?

This will greatly improve access, but not for everyone," says Daniel Grossman, a University of California, San Francisco researcher.